# Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects

> **NCT06119958** · PHASE1 · UNKNOWN · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 32 (estimated)

## Conditions studied

- Drug Drug Interaction

## Interventions

- **DRUG:** DWC202313
- **DRUG:** DWC202314

## Key facts

- **NCT ID:** NCT06119958
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-27
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06119958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06119958, "Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06119958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*